Contrast Induced-Nephropathy

CorMedix (CRMD): Undervalued and Under Investor’s Radar
istockanalyst
Sat, 12/11/10 - 12:47 pm
CorMedix
cardiorenal
Neutrolin
Deferiprone
Contrast Induced-Nephropathy
catheters
MYTHOS RenalGuard® Trial Demonstrates Greater Efficacy Than Current Standard of Care
Thu, 09/23/10 - 09:56 am
PLC Systems Inc.
RenalGuard
Contrast Induced-Nephropathy